Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > I-Flow Donates Infection-Fighting Wound Care Product to Help Earthquake Victims in China

Abstract:
Company's Subsidiary, AcryMed, Responds to Plea from Chinese Partner; Ships Cases of SilvaSorb® Antimicrobial Gel to Quake Site With Help from Local FedEx

I-Flow Donates Infection-Fighting Wound Care Product to Help Earthquake Victims in China

LAKE FOREST, CA | Posted on May 20th, 2008

I-Flow Corporation (NASDAQ:IFLO), through its wholly-owned subsidiary AcryMed, announced today it has donated 1,000 tubes of its SilvaSorb antimicrobial gel product to the Red Cross of China for distribution to earthquake victims in Sichuan, China. The company offered its help last week by donating the available product and arranged for immediate shipping to China after a plea from its Chinese partner.

According to reports out of China, the recent earthquake has left thousands injured and created unclean conditions, raising fear of the spread of dangerous infections. AcryMed's SilvaSorb is a unique topical gel containing a highly effective silver antimicrobial compound that kills bacteria and fungus commonly associated with wounds and burns. Those who use it may significantly reduce the risk of contracting a life-threatening infection.

"Stemming the tide of infections will be critical to saving lives," said AcryMed's chief technology officer and founder, Bruce Gibbins, a microbiologist. "SilvaSorb is a gel that requires no training to apply and the antimicrobial technology it contains can have a significant impact on reducing life-threatening infections contracted by the wounded. We were glad to be able to assist the relief efforts."

Gibbins further commented, "Three years ago we were also able to assist Medical Teams International in helping the Tsunami victims in South Asia. As a company that is committed to helping those who really need it, we are proud to be able to contribute what we can."

SilvaSorb was recently cleared by the FDA for over the counter distribution and is available as a CVS brand anti-microbial silver gel in CVS/pharmacy stores throughout the United States. SilvaSorb is also distributed to medical professionals in the U.S. by Medline Industries.

####

About I-Flow Corporation
I-Flow Corporation (www.IFLO.com) is improving surgical outcomes by designing, developing and marketing technically-advanced, low-cost drug delivery systems and innovative surgical products for post-surgical pain relief and surgical site care.

AcryMed is a pioneering leader at the forefront of innovations in the fields of infection control and wound healing. The company’s SilvaSorb® products for advanced wound care and SilvaGard® nanoparticle surface treatment for medical devices are among the breakthrough technologies that have distinguished AcryMed as an industry leader. A wholly-owned subsidiary of I-Flow Corporation, AcryMed maintains on-site GMP/ISO certified manufacturing and lab facilities at its Beaverton, Oregon headquarters. For more information on AcryMed visit www.AcryMed.com.

For more information, please click here

Contacts:
I-Flow Corporation
Orlando Rodrigues
Vice President, Marketing
949-206-2619

or
Brenner Associates Public Relations
AcryMed
Brad Brenner
503-736-0610

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Engineers develop new materials for hydrogen storage April 15th, 2014

Nanocrystalline cellulose modified into an efficient viral inhibitor April 15th, 2014

Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014

A molecular approach to solar power: Switchable material could harness the power of the sun — even when it’s not shining April 15th, 2014

Nanomedicine

Nanocrystalline cellulose modified into an efficient viral inhibitor April 15th, 2014

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Nano shake-up: UD researchers demonstrate that processing can affect size of nanocarriers for targeted drug delivery April 14th, 2014

Premier Healthcare Pitch Competition comes to Atlanta this May April 12th, 2014

Announcements

Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014

A molecular approach to solar power: Switchable material could harness the power of the sun — even when it’s not shining April 15th, 2014

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014

Human Interest/Art

Harry Potter-style invisibility cloaks: A real possibility next Christmas? Forget socks and shaving foam, the big kids of tomorrow want an invisible cloak for Christmas December 19th, 2013

Chicago Awareness Organization First Not-for-Profit to Sponsor Dog Training to Detect Ovarian Cancer Odorants December 12th, 2013

ZEISS Microscopes used to create images for Art Exhibit at Midway Airport: Art of Science: Images from the Institute for Genomic Biology October 25th, 2013

New potential for touch screens found at your fingertips September 17th, 2013

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE